Solei offers a thoughtfully curated assortment
of products and strains designed to enhance a wide variety of
individual and shared experiences
LEAMINGTON, ON, April 17, 2018 /CNW/ - Aphria Inc.
("Aphria" or the "Company") (TSX: APH and
US OTC: APHQF) today introduced its first brand designed for
Canada's new adult-use market,
Solei Sungrown Cannabis ("Solei"). Solei has been designed
to demystify cannabis and will enable current and novice users
alike to control and enrich their cannabis journey, pairing an
assortment of carefully curated products and strains with different
experiences.
Solei was created specifically for what will be one of the
largest segments in the Canadian cannabis landscape, defined not by
age, gender or geography, but rather by a shared mindset and
attitude. Their motivations are not driven by a desire to alter
their state of mind, but rather by a desire to open themselves up
to new experiences.
"When we embarked on our journey to develop Aphria's portfolio
of adult-use brands, we were committed to understanding what the
landscape of new cannabis users would look like," said Megan McCrae, VP of Marketing and Communications
at Aphria. "Solei was developed to offer a thoughtfully curated
assortment of strains, presented with uncomplicated language. Solei
is intended to complement a range of experiences from moments of
mindful self-reflection to shared social experiences."
Once adult-use cannabis is legalized in Canada and as regulations allow, the Solei
brand will be available in a wide variety of product consumption
alternatives to consumers. All Solei products will follow
easy-to-use instructions designed specifically to demystify and
simplify cannabis use.
Powered by the sun, Solei embodies social responsibility and
sustainability. It will be produced in Aphria's eco-friendly
greenhouses in Leamington,
Ontario, which use approximately 1/12th of the
power of other indoor growing operations. Aphria also employs a
wide variety of energy and resource-efficient growing techniques to
ensure that natural resources are preserved and respected.
"This is a transformative day for Aphria, as we launch the first
of many adult-use brands we will be bringing to the Canadian market
in the months and years to come," said Vic
Neufeld, CEO of Aphria. "After more than a year of research
and thoughtful development, we are thrilled to finally introduce
Solei, a brand that will not only set Aphria apart in the Canadian
adult-use market but also will elevate our reputation as a leader
in the global cannabis industry. Solei is the perfect expression of
our commitment to the long-term potential of the adult-use market.
With our expertise in growing high-quality, clean and safe
cannabis, and growing it at scale, we are well-positioned to meet
the anticipated demand in Canada,
while continuing to develop an incredible portfolio of brands for
consumers across the country."
www.solei.ca
We Have a Good Thing Growing.
About Aphria
Aphria Inc., one of Canada's
lowest cost producers, produces, supplies and sells medical
cannabis. Located in Leamington,
Ontario, the greenhouse capital of Canada, Aphria is truly powered by sunlight
allowing for the most natural growing conditions available. Aphria
is committed to providing pharma-grade medical cannabis, superior
patient care while balancing patient economics and returns to
shareholders.
For more information, visit: aphria.ca
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain
information in this news release constitutes forward-looking
statements under applicable securities laws. Any statements that
are contained in this news release that are not statements of
historical fact may be deemed to be forward-looking statements.
Forward looking statements are often identified by terms such as
"may", "should", "anticipate", "expect", "potential", "believe",
"intend" or the negative of these terms and similar expressions.
Forward-looking statements in this news release include, but are
not limited to, statements with respect to internal expectations,
estimated margins, expectations with respect to actual production
volumes, expectations for future growing capacity and costs, the
completion of any capital project or expansions, and expectations
with respect to future production costs. Forward-looking statements
necessarily involve known and unknown risks, including, without
limitation, risks associated with general economic conditions;
adverse industry events; marketing costs; loss of markets; future
legislative and regulatory developments involving marijuana;
inability to access sufficient capital from internal and external
sources, and/or inability to access sufficient capital on
favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory
matters; the ability of Aphria to implement its business
strategies; competition; crop failure; currency and interest rate
fluctuations and other risks.
Readers are cautioned that the foregoing list is not exhaustive.
Readers are further cautioned not to place undue reliance on
forward-looking statements as there can be no assurance that the
plans, intentions or expectations upon which they are placed will
occur. Such information, although considered reasonable by
management at the time of preparation, may prove to be incorrect
and actual results may differ materially from those
anticipated.
Forward-looking statements contained in this news release are
expressly qualified by this cautionary statement.
SOURCE Aphria Inc.